In addition, digoxin can effectively maintain the redox homeostasis of hepatocytes, inhibit the activation of the HIF-1α pathway, and protect the liver from inflammation and injury in NASH and ASH (Ouyang et al., 2018). Here, HIF1A is linked to metabolic dysfunction-associated steatohepatitis.